4 Stocks Pushing The Health Services Industry Higher
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our modelAll three major indices are trading down today with the Dow Jones Industrial Average (^DJI) trading down 115 points (-0.8%) at 13,894 as of Monday, Feb. 4, 2013, 11:49 AM ET. The NYSE advances/declines ratio sits at 654 issues advancing vs. 2,230 declining with 132 unchanged.The Health Services industry currently sits down 0.9% versus the S&P 500, which is down 0.9%. On the negative front, top decliners within the industry include Thermo Fisher Scientific (TMO), down 2.6%, Life Technologies (LIFE), down 2.2%, Waters Corporation (WAT), down 2.3%, Stryker Corporation (SYK), down 1.3% and DaVita HealthCare Partners (DVA), down 1.2%.TheStreet Ratings group would like to highlight 4 stocks pushing the industry higher today:4. Opko Health (OPK) is one of the companies pushing the Health Services industry higher today. As of noon trading, Opko Health is up $0.28 (4.2%) to $7.01 on average volume Thus far, 1.4 million shares of Opko Health exchanged hands as compared to its average daily volume of 2.0 million shares. The stock has ranged in price between $6.70-$7.03 after having opened the day at $6.80 as compared to the previous trading day's close of $6.73. Opko Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies primarily in the United States, Chile, and Mexico. Opko Health has a market cap of $1.9 billion and is part of the health care sector. Shares are up 33.5% year to date as of the close of trading on Friday. Currently there are 3 analysts that rate Opko Health a buy, no analysts rate it a sell, and none rate it a hold.TheStreet Ratings rates Opko Health as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income and feeble growth in the company's earnings per share. Get the full Opko Health Ratings Report now.It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE
Latest Headlines about STJ
-
St. Jude Medical Becomes #114 Most Shorted S&P 500 Component, Replacing Murphy Oil
02:55PM 05/10/13
-
St. Jude Medical Gets Too Much Praise
06:30AM 05/06/13
-
St. Jude Medical Becomes #173 Most Shorted S&P 500 Component, Replacing Fluor Corp.
03:02PM 04/10/13
-
Analysts' Actions: AIG MSFT SIRI MO LVS
09:12AM 01/10/13
-
5 Stocks Paying You Double-Digit Shareholder Yield
12:58PM 12/27/12
-
TheStreet Ratings Top 10 Rating Changes
03:02PM 12/10/12
-
Stocks Pare Losses, End Flat for the Day
04:41PM 11/30/12
Latest from TheStreet Wire
-
Mead Johnson Nutrition Rises On Unusually High Volume (MJN)
04:14PM 05/22/13
-
Axiall Stock Falls On Unusually High Volume (AXLL)
04:04PM 05/22/13
-
Alexandria Real Estate Equities Stock Falls On Unusually High Volume (ARE)
03:54PM 05/22/13
-
Sony Stock Falls On Unusually High Volume (SNE)
03:50PM 05/22/13
-
Tempur-Pedic International Stock Falls On Unusually High Volume (TPX)
03:29PM 05/22/13
-
Warner Chilcott Stock Falls On Unusually High Volume (WCRX)
03:24PM 05/22/13
-
Pfizer Rises On Unusually High Volume (PFE)
03:08PM 05/22/13
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
